FDA Inspection

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)June 27, 2017

FDA Inspection 1019795 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - June 27, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals), with an inspection on June 27, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
Inspection Date: June 27, 2017
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · e4847276-f3f0-4073-a7d2-e60f6d62c3c5